45 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
30 Jan 24
Entry into a Material Definitive Agreement
9:29am
that contained herein and the results of independent investigation by Subscriber without any influence by Company or those acting on Company’s behalf
8-K
EX-10.1
qeivv5tnkd1q
5 May 23
Departure of Directors or Certain Officers
4:59pm
8-K
EX-10.1
jgwiwn tdjhbsnyums
17 Jul 20
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-1.1
9oc9x98lxtrch4g
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
8-K
EX-10.1
ydy7k
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
8-K
EX-4.1
l8fb47oev 1ukx
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
8-K
EX-1.1
cypk rt1mavjo
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm
8-K
EX-10.1
87f0tfwuq6p6ae lp
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm